.Pharmacolibrary.Drugs.ATC.C.C09AA01

Information

name:Captopril
ATC code:C09AA01
route:oral
n-compartments1

Captopril is an angiotensin-converting enzyme (ACE) inhibitor used in the management of hypertension, congestive heart failure, diabetic nephropathy, and post-myocardial infarction. It is an approved drug currently used in clinical practice.

Pharmacokinetics

Healthy adult volunteers (both sexes), single oral dose, fasting state.

References

  1. Pereira, CM, et al., & Collins-Nakai, RL (1991). The pharmacokinetics of captopril in infants with congestive heart failure. Therapeutic drug monitoring 13(3) 209–214. DOI:10.1097/00007691-199105000-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1926273

  2. DiBianco, R (1986). Adverse reactions with angiotensin converting enzyme (ACE) inhibitors. Medical toxicology 1(2) 122–141. DOI:10.1007/BF03259832 PUBMED:https://pubmed.ncbi.nlm.nih.gov/3023783

  3. Creasey, WA, et al., & Sugerman, AA (1986). Pharmacokinetics of captopril in elderly healthy male volunteers. Journal of clinical pharmacology 26(4) 264–268. DOI:10.1002/j.1552-4604.1986.tb03521.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/3517077

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos